4//SEC Filing
DENNER ALEXANDER J 4
Accession 0000950170-25-087350
CIK 0001446847other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:05 PM ET
Size
7.8 KB
Accession
0000950170-25-087350
Insider Transaction Report
Form 4
Sarissa Capital Management LP
10% Owner
Transactions
- Award
Class A Common Stock
2025-06-13+24,193→ 235,962 total
Holdings
- 16,390,000(indirect: See Footnote)
Class A Common Stock
Denner Alexander J
Director10% Owner
Transactions
- Award
Class A Common Stock
2025-06-13+24,193→ 235,962 total
Holdings
- 16,390,000(indirect: See Footnote)
Class A Common Stock
Footnotes (2)
- [F1]Issued pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024.
- [F2]Consists of shares that are held by Sarissa Capital Management LP ("Sarissa Capital") or by the funds and other investment vehicles (the "Sarissa Funds") for which SarissaCapital serves as investment advisor. Dr. Denner is the Chief Investment Officer of Sarissa Capital and the managing member, general partner or other control party of theSarissa Funds. By virtue of the foregoing, Dr. Denner may be deemed to indirectly beneficially own the shares that these funds directly beneficially own. Each of SarissaCapital, the Sarissa Funds and Dr. Denner disclaims beneficial ownership of these shares except, in each case, to the extent of their pecuniary interest therein.
Documents
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeother
Related Parties
1- filerCIK 0001361754
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:05 PM ET
- Size
- 7.8 KB